Login
Nautilus Biotechnology Inc logo

Nautilus Biotechnology Inc

nautilus.bio

Nautilus Biotechnology Inc (NASDAQ: NAUT) is a biotechnology company developing a platform for single-molecule protein analysis. The filing excerpts provided do not contain sufficient detail to describe the revenue model, competitive position, geographic footprint, customer base, or financial metrics with the specificity required for a grounded summary. No revenue figures, product commercialization status, customer counts, or competitor names are supported by the excerpts available from the 10-K filed 2026-02-26 (accession 000180880526000011). A complete description cannot be constructed without fabricating facts not present in the source material.

Financial Snapshot

Revenue
TTM
$190.0K
Gross Margin
TTM
92.11%
Net Income
TTM
-$56.52M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
1014.31%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
Book Value
2026 Q2
$131.1M
Cash
2026 Q2
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$37.68M

Stock Price

Loading...
Market Cap: $124.33 Million

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support